🔬 This facility aims to tackle challenges in scaling affordable manufacturing of stem cell-derived therapies.
🏭 Located in the CGT Catapult’s Stevenage Centre, it’s set to produce up to 1,500 autologous doses annually by September 2026.
🚀 Mytos’ iDEM™ technology enhances efficiency and reduces manufacturing costs.
🌍 This initiative could increase global access to regenerative medicine.
Introduction:
The article discusses the recent launch of Mytos’ automated contract development and manufacturing organization (CDMO), aimed at addressing significant challenges in the scalable and affordable production of stem cell-derived therapies within the field of regenerative medicine.
- Mytos has introduced an automated CDMO to facilitate the manufacturing of stem cell therapies, which have historically faced scalability and cost barriers.
- The first facility will be located at the Cell and Gene Therapy Catapult’s Stevenage Manufacturing Innovation Centre and is expected to be clinically ready by September 2026, targeting significant annual production capacities.
- The implementation of Mytos’ proprietary iDEM™ automation technology will enhance the efficiency and consistency of stem cell therapy production, reducing costs significantly.
- CGT Catapult will collaborate with Mytos to innovate and validate their manufacturing technologies while providing a framework for the transition to Good Manufacturing Practice (GMP) environments.
- The initiative represents a strategic move to build a global manufacturing presence capable of delivering regenerative medicines to a larger patient population, thereby enhancing the accessibility of advanced therapies.
Conclusion:
Mytos’ automated CDMO marks a pivotal advancement in overcoming operational challenges that have hindered the scalability of regenerative medicine. By leveraging automation and strategic collaborations, Mytos aims to revolutionize the production landscape for stem cell-derived therapies, thus facilitating their widespread adoption and improving patient access to innovative treatments.
